Actas urologicas espanolas最新文献

{"title":"Comentario sobre «Análisis de la supervivencia del dispositivo y los factores predictivos de la misma en una cohorte de pacientes intervenidos de esfínter urinario artificial masculino». Respuesta de los autores","authors":"C. Minguez Ojeda, A. Artiles Medina","doi":"10.1016/j.acuro.2025.501840","DOIUrl":"10.1016/j.acuro.2025.501840","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501840"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de la lista de espera quirúrgica en los resultados oncológicos de la prostatectomía radical en pacientes con cáncer de próstata de riesgo intermedio y alto","authors":"P. de Pablos-Rodríguez ,&nbsp;P. Guedes Oliva ,&nbsp;Á. Gómez Ferrer ,&nbsp;M. Beamud Cortés ,&nbsp;A. Wong Gutiérrez ,&nbsp;C. Gutiérrez Castañé ,&nbsp;A. Calatrava Fons ,&nbsp;J. Aliaga Patiño ,&nbsp;Á. García Cortés ,&nbsp;J. Agustín López ,&nbsp;A. Collado Serra ,&nbsp;V. Rodríguez Part ,&nbsp;J.L. Casanova Ramón Borja","doi":"10.1016/j.acuro.2025.501910","DOIUrl":"10.1016/j.acuro.2025.501910","url":null,"abstract":"<div><h3>Introduction</h3><div>The prognosis of localized prostate cancer (PCa) following radical treatment is generally favorable, although up to 46% of patients may still experience adverse outcomes. The impact of delayed surgery in intermediate-risk (IR) or high-risk (HR) patients remains under discussion. This study evaluates its association with oncological outcomes.</div></div><div><h3>Materials and methods</h3><div>Retrospective study of 2,296 patients with IR and HR PCa who underwent radical prostatectomy (RP) between 1986 and 2025. Upgrading, upstaging, positive margins, PSA persistence, and lymph node involvement were analyzed. Waiting time was grouped into &lt;<!--> <!-->3, 3–6, and &gt;<!--> <!-->6 months.</div></div><div><h3>Results</h3><div>The median waiting time was 3.5 months. Eighty-five percent of patients were operated on within 6 months. At 5 years, no difference was detected between waiting time and time to biochemical recurrence (BCR) when comparing the &lt;<!--> <!-->3-month group with the 3–6-month group (HR 0.93; 95% <span>C</span>I 0.76–1.13) and the &gt;<!--> <!-->6 months group (HR 0.74; 95% CI 0.53–1.04) among IR patients. In HR patients, no differences were observed either: 3–6 months (HR 0.85; 95% CI 0.71–1.01) and &gt;<!--> <!-->6 months (HR 0.79; 95% CI 0.61–1.03). No increased risk of adverse pathological outcomes was found with longer delays.</div></div><div><h3>Conclusions</h3><div>A waiting time of ≤<!--> <!-->6 months was not associated with worse oncological prognosis, supporting its safety in IR or HR PCa.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501910"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"¿Es factible el abordaje retroperitoneal utilizando la plataforma robótica de puerto único para la nefrectomía nativa tras el trasplante renal?","authors":"H.B. Haberal ,&nbsp;F.M. Valenzi ,&nbsp;V. Santarelli ,&nbsp;S. Crivellaro","doi":"10.1016/j.acuro.2025.501797","DOIUrl":"10.1016/j.acuro.2025.501797","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501797"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Quimioterapia neoadyuvante intravesical intensiva en el cáncer vesical no músculo invasivo recurrente de grado bajo y riesgo intermedio: ¿una alternativa real a la resección transuretral de vejiga?","authors":"G. Villoldo ,&nbsp;A. Kamat ,&nbsp;G. Fernández Candia","doi":"10.1016/j.acuro.2025.501829","DOIUrl":"10.1016/j.acuro.2025.501829","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501829"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Resultados de resonancia magnética y rebiopsia confirmatoria durante la vigilancia activa en pacientes con cáncer de próstata de grupo de grado 2","authors":"F. Sanguedolce ,&nbsp;M. Baboudjian ,&nbsp;A. Redondo Ríos ,&nbsp;R. Leni ,&nbsp;M. Oderda ,&nbsp;A. Peyrottes ,&nbsp;C. Kesch ,&nbsp;M. Al-Nader ,&nbsp;A. Uleri ,&nbsp;T. Long-Depaquit ,&nbsp;C. Dariane ,&nbsp;H. Baud ,&nbsp;J. Olivier ,&nbsp;V. Benard ,&nbsp;O. Windisch ,&nbsp;M. Valerio ,&nbsp;G. Gandaglia ,&nbsp;G. Ploussard","doi":"10.1016/j.acuro.2025.501924","DOIUrl":"10.1016/j.acuro.2025.501924","url":null,"abstract":"<div><h3>Introduction</h3><div>To report the results of confirmatory MRI/biopsy in a European cohort of MRI-selected patients with Gleason Grade Group (GG) 2 prostate cancer (PCa) in active surveillance (AS).</div></div><div><h3>Methods</h3><div>Multicenter study enrolled patients with GG2 PCa managed by AS between 2016-2024. Serial MRI scans were interpreted according to PRECISE recommendations. Diagnostic accuracy of PRECISE score to predict upgrading on confirmatory biopsy was assessed by calculating sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) with 95% Confident Intervals (CIs).</div></div><div><h3>Results</h3><div>A total of 77 patients with GG2 PCa was included, with a PI-RADS 4-5 in 48 patients (63%). On confirmatory MRI, 32 cases were classified as PRECISE 4-5 (42%). On confirmatory biopsy, 39 patients (51%) were downgraded to GG0-1, 27 patients (35%) were GG 2 and upgrading occurred in 11 cases (14%). Sensitivity, specificity, NPV and PPV of the PRECISE score 4-5 to detect upgrading was 63.6% (95%CI 31–89), 62.1% (95%CI, 49-74), 91.1% (95%CI, 82-96) and 21.8% (95%CI, 14-32), respectively. In multivariable Cox hazards regression analysis, downgrading at confirmatory biopsy was significantly associated with a reduced risk of subsequent GG3 reclassification (HR 0.125, 95%CI, 0.277-0.560, p<!--> <!-->=<!--> <!-->0.002) and definitive treatment (HR 0.409, 95%CI, 0.199-0.839, p<!--> <!-->=<!--> <!-->0.015).</div></div><div><h3>Conclusion</h3><div>MRI selection of patients with GG2 PCa in AS allows better initial characterization of the disease. The absence of progression on MRI indicates a very low risk of grade reclassification, but signs of imaging progression are not always predictive of progression and should not be considered alone for prompting active treatment.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501924"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Disfunción eréctil y variables relacionadas con el uso de esteroides anabólicos. Una revisión de revisiones","authors":"M. García Vidal ,&nbsp;A. Vázquez-Méndez ,&nbsp;I. Mollinedo-Cardalda ,&nbsp;I. de Oliveira","doi":"10.1016/j.acuro.2026.501926","DOIUrl":"10.1016/j.acuro.2026.501926","url":null,"abstract":"<div><h3>Introduction and objective</h3><div>Anabolic androgenic steroids are synthetic substances that mimic testosterone, promoting increased strength and muscle mass. Although they were initially used to achieve an increase in sports performance, nowadays most users are not professional athletes. Their use can cause various adverse effects, but despite these, they continue to be used to improve aesthetic and performance aspects. The purpose of this review of reviews was to examine the effects of anabolic androgenic steroids on male erectile function and related variables.</div></div><div><h3>Materials and methods</h3><div>A systematised literature review was carried out in Medline, Scopus, Pubmed, Cinahl, ScienceDirect, SPORTDiscus databases in July 2025. The search terms were ‘Anabolic Androgenic Steroids’, ‘Erectile Dysfunction’ and ‘Adverse effect’. The A Measurement Tool to Assess Systematic Review (AMSTAR-2) was used to assess the methodological quality of the selected reviews.</div></div><div><h3>Results</h3><div>Six systematic reviews were valid. Assessment of methodological quality using the AMSTAR-2 scale revealed that four reviews had critically low confidence, one review had low confidence, and one review had medium confidence. Despite methodological limitations, the reviews showed common findings associating prolonged use of anabolic androgenic steroids with the reduction in hormone levels, testosterone levels and reproductive function, leading to erectile dysfunction, in young adults (28-33 years) involved in weightlifting, powerlifting or bodybuilding.</div></div><div><h3>Conclusions</h3><div>The use of anabolic androgenic steroids appears to have a negative impact on erectile function and male reproductive health, with evidence of hypogonadism and hormonal alterations.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501926"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factores predictivos del desarrollo de estenosis uretral en pacientes con tumor vesical: el papel de la terapia intravesical con BCG","authors":"İ.E. Ergín ,&nbsp;A. Sanci ,&nbsp;E. Hepşen ,&nbsp;K. Sarıkaya ,&nbsp;M. Yığman ,&nbsp;A.L. Sağnak ,&nbsp;A.N. Karakoyunlu","doi":"10.1016/j.acuro.2025.501908","DOIUrl":"10.1016/j.acuro.2025.501908","url":null,"abstract":"<div><h3>Objective</h3><div>This study aims to investigate the predictive role of intravesical Bacillus Calmette-Guérin (BCG) therapy on urethral stricture development in male patients undergoing bladder tumor surveillance, while also assessing the impact of repeated urethral instrumentation on stricture risk.</div></div><div><h3>Methods</h3><div>This retrospective study included male patients aged 18–90 with non-muscle invasive bladder tumors followed between 2018 and 2024. Demographics, cystoscopy and TUR procedures, intravesical treatments (BCG and chemotherapy), and urethral stricture diagnosis were recorded. Urethral stricture was confirmed by uroflowmetry, cystoscopy, and urethrography. Patients with prior urethral stricture or incomplete records were excluded. Statistical analyses included logistic regression to identify predictors of stricture development, adjusting for age and comorbidities. Sample size was calculated to ensure adequate power to detect a 15% difference in stricture incidence related to BCG therapy.</div></div><div><h3>Results</h3><div>A total of 187 male patients were analyzed, with a 12.3% urethral stricture incidence. BCG therapy was administered to 32.6% of patients and significantly increased stricture risk (OR: 4.11, p<!--> <!-->=<!--> <!-->0.015). Each additional dose was associated with an increased risk (OR: 2.11, p<!--> <!-->=<!--> <!-->0.001). TURP (OR: 2.95, p<!--> <!-->=<!--> <!-->0.045) and the number of cystoscopies (OR: 1.42 per procedure, p<!--> <!-->=<!--> <!-->0.040) were also significant predictors. Tumor size ≥3<!--> <!-->cm was associated with higher risk (OR: 1.88, p<!--> <!-->=<!--> <!-->0.037). Spearman analysis showed positive correlations between stricture severity and both BCG doses and cystoscopy number.</div></div><div><h3>Conclusion</h3><div>Intravesical BCG therapy, repeated cystoscopies, and TURP increase urethral stricture risk in bladder tumor patients. Preventive measures and careful monitoring are essential to reduce urethral complications.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501908"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801972","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comparación de la mininefrolitotomía percutánea supina guiada por ecografía y por fluoroscopia: estudio retrospectivo unicéntrico basado en la experiencia clínica y la bibliografía actual","authors":"E. Ördek ,&nbsp;S. Toksöz ,&nbsp;K. Gümüş ,&nbsp;İ. Özdoğan","doi":"10.1016/j.acuro.2026.501930","DOIUrl":"10.1016/j.acuro.2026.501930","url":null,"abstract":"<div><h3>Introduction</h3><div>The utilisation of fluoroscopy in percutaneous nephrolithotomy (PCNL) gives rise to concerns regarding radiation exposure, thus necessitating the exploration of alternative methodologies. This study sets out to compare the efficacy and safety of ultrasound-guided supine mini-PCNL and fluoroscopy-guided supine mini-PCNL for renal stone management.</div></div><div><h3>Methods</h3><div>Adult patients with renal stones ≥15<!--> <!-->mm who underwent supine mini-PCNL were retrospectively reviewed. Patients were categorized into ultrasound-guided (US-PCNL, n<!--> <!-->=<!--> <!-->64) and fluoroscopy-guided (FL-PCNL, n<!--> <!-->=<!--> <!-->84) groups. Clinical variables, including operative time, number of puncture attempts, fluoroscopy duration, perioperative hemoglobin change, transfusion requirement, stone-free rate, complication rate, and length of hospital stay, were analysed. Surgical outcomes between the groups were compared using independent t-test or Mann-Whitney U test as appropriate. Wilcoxon test was used for dependent variables, and Chi-square test for categorical data.</div></div><div><h3>Results</h3><div>The US-PCNL group had a significantly shorter operative time and puncture time compared to the FL-PCNL group (<em>P</em>&lt;.05). No significant differences were found between the groups in terms of puncture attempts, tract formation rates, or stone-free rates (<em>P</em>&gt;.05). Postoperative complications, such as fever and the need for additional interventions, were similar between groups (<em>P</em>&gt;.05). Notably, the FL-PCNL group had a mean fluoroscopy duration of 6.3<!--> <!-->minutes, while the US-PCNL group had none.</div></div><div><h3>Conclusions</h3><div>Ultrasound-guided supine mini-PCNL offers a promising, radiation-free alternative to fluoroscopy in renal stone management. This study shows comparable outcomes between the two techniques, emphasizing the potential of ultrasound to improve patient safety in endourology.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501930"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de las reuniones multidisciplinarias en el manejo del cáncer de próstata metastásico en un centro de referencia","authors":"L.A. Pereira do Nascimento ,&nbsp;R.M. Mariano da Costa Junior ,&nbsp;V. Ramos Machado ,&nbsp;J.J. Saab Filho ,&nbsp;M.H. Bueno Bavaresco ,&nbsp;R. Panhoca ,&nbsp;W. Aparecido França ,&nbsp;L.A. Seabra Rios ,&nbsp;G. Pinheiro Soares","doi":"10.1016/j.acuro.2025.501905","DOIUrl":"10.1016/j.acuro.2025.501905","url":null,"abstract":"<div><h3>Introduction</h3><div>The management of metastatic prostate cancer (MPC) is complex and requires timely, coordinated decision-making across multiple specialties. Multidisciplinary team meetings (MDMs) have been increasingly adopted to optimize treatment planning, yet evidence regarding their impact on objective clinical outcomes in genitourinary cancers remains limited.</div></div><div><h3>Methods</h3><div>This retrospective, single-center cohort study compared two periods of MPC care: before MDM implementation (2018-2019) and after implementation (2021-2022). Patients were identified through institutional records. Demographic data, treatment timelines, therapeutic choices, and follow-up patterns were collected. Primary outcomes included time to clinical oncology consultation, time to treatment initiation, systemic therapy use, and follow-up adherence.</div></div><div><h3>Results</h3><div>One hundred thirty-nine patients were included, 72 in the 2018-2019 period and 67 in the 2021-2022 period. There was a significant reduction in the time taken to consult clinical oncology (<em>P</em>&lt;.05) and to start treatment (<em>P</em>&lt;.05). Systemic therapy started predominantly in the castration-sensitive setting (70.2 vs 14.3%; <em>P</em>&lt;.001). The MDM promoted a higher quality of treatment, with a greater prescription of docetaxel and novel antiandrogens (95.7 vs 64.3%; <em>P</em>=.001) and zoledronic acid in the castration-resistant phase (92.5 vs 79.2%; <em>P</em>=.047). The MDM discussion optimized follow-up, with loss to follow-up observed in only 7.5% of cases (<em>P</em>&lt;.001).</div></div><div><h3>Conclusion</h3><div>The implementation of multidisciplinary team meetings significantly improved the timeliness, quality, and adherence to oncological care for patients with metastatic prostate cancer. MDMs should be incorporated as a standard component of care in institutions managing this population.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501905"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Conducto ileal retrosigmoideo frente a técnicas tradicionales tras cistectomía radical: impacto en la incidencia de estenosis de la anastomosis ureteroileal","authors":"C. Casanova-Martín ,&nbsp;M. Álvarez-Maestro ,&nbsp;A. Rodríguez-Serrano ,&nbsp;A. Gómez-Villanueva ,&nbsp;A. Aguilera-Bazán ,&nbsp;M. Serrano-Liesa ,&nbsp;J.M. Alonso-Dorrego ,&nbsp;M.Á. Ortega-Núñez ,&nbsp;E. Ríos-González ,&nbsp;L. Martínez-Piñeiro Lorenzo","doi":"10.1016/j.acuro.2026.501934","DOIUrl":"10.1016/j.acuro.2026.501934","url":null,"abstract":"<div><h3>Introduction and objective</h3><div>Ureteroileal anastomotic stricture (UAS) is a relevant complication after radical cystectomy (RC). The retrosigmoid ileal conduit (RIC) may reduce its incidence by avoiding left ureteral transposition.</div></div><div><h3>Objective</h3><div>To compare the incidence of UAS, perioperative outcomes, and length of stay between RIC and conventional urinary diversions (Bricker / Wallace).</div></div><div><h3>Material and methods</h3><div>Retrospective, single-center observational study. All patients undergoing RC with bilateral urinary diversion were included: RIC between 01/2021-12/2024 and conventional techniques between 01/2018-12/2020. <em>Primary variable:</em> Multivariable logistic regression was performed using: age, body mass index (BMI), prior urinary tract dilation, Charlson Comorbidity Index (CCI), Eastern Cooperative Oncology Group (ECOG) score, and surgical technique. <em>Secondary variables:</em> operative time, 30-day postoperative complications (grouped as minor complications [Clavien 1-2] and major complications [Clavien ≥3]), time to stricture, length of hospital stay, and follow-up time after surgery.</div></div><div><h3>Results</h3><div>Seventy-one patients were analyzed: 36 RIC and 35 controls, with comparable baseline characteristics. UAS presented an incidence of 2.8% in RIC group and 22.9% in controls; the RIC technique was associated with a lower adjusted risk (OR: 0.05; 95% CI: 0.002-0.35; <em>P</em>=.011). Operative time was shorter with RIC (median: 292 [IQR: 274-315] vs. 330 [308-360] min; p<!--> <!-->=<!--> <!-->0.00025). There were no differences in major complications (11.1 vs. 17.1%; <em>P</em>=.51) or minor complications (33.3 vs. 42.9%; <em>P</em>=.41), nor in hospital stay (11.5 vs. 9 days; <em>P</em>=.23). The median follow-up was 18 months (RIC) and 39 months (control).</div></div><div><h3>Conclusions</h3><div>In our series, RIC significantly reduced UAS without increasing morbidity and was associated with a shorter operative time compared with traditional techniques. The results support the anatomical consistency and reproducibility of the technique.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 4","pages":"Article 501934"},"PeriodicalIF":1.2,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147801973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}